特一药业 (002728.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

31.5x

Market Cap

CNY 4.41B

MomentumView details →

1D Return

−3.37%

YTD Return

−17.33%

RSI (14)

47.3

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

31.5x

Market Cap

CNY 4.41B

RSI (14)

47.3

MomentumView details →

1D Return

−3.37%

YTD Return

−17.33%

ProfitabilityView details →

Gross Margin

52.66%

Net Margin

9.04%

EBITDA Margin

17.99%

ROE (TTM)

4.11%

ROA (TTM)

3.26%

Asset Turnover

0.36x

GrowthView details →

Revenue YoY

+2.56%

EPS YoY

+83.46%

FCF YoY

+3349.46%

Revenue CAGR 3Y

+1.41%

EPS CAGR 3Y

−34.52%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

CNY 0.01

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

CNY 0.00

Avg Surprise (4Q)

—

Rev Surprise

129.31%

Capital & dividendView details →

Debt/Equity

0.16x

Current Ratio

2.01x

Quick Ratio

1.43x

Div Yield

1.67%

Div Rate

CNY 0.15

Div Growth 1Y

+200.00%

Financials snapshotView financials →

Revenue (TTM)

839.27M

Net Income (TTM)

75.87M

Op. CF (TTM)

166.38M

Latest newsMore news →

Teyi Pharmaceutical announced its first-half 2026 results: net profit attributable to shareholders was 31.1081 million yuan, down 18.15% year-on-year.16d ago

Similar companies

英联股份002846.SZ 御银股份002177.SZ 岳阳兴长000819.SZ 和顺科技301237.SZ 世名科技300522.SZ 三维化学002469.SZ Find similar companies →

Latest newsMore news →

Teyi Pharmaceutical announced its first-half 2026 results: net profit attributable to shareholders was 31.1081 million yuan, down 18.15% year-on-year.16d ago